<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-0KHH0OTN</identifier><date>2014</date><creator>Janež, Andrej</creator><creator>Jensterle Sever, Mojca</creator><creator>Rakuša, Matej</creator><relation>documents/doc/0/URN_NBN_SI_doc-0KHH0OTN_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-0KHH0OTN_001.txt</relation><format format_type="issue">3</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 221-226</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">28106791</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-0KHH0OTN</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">cardiovascular disease</subject><subject language_type_id="slv">debelost</subject><subject language_type_id="slv">kardiovaskularne bolezni</subject><subject language_type_id="slv">metabolični sindrom</subject><subject language_type_id="slv">ocena tveganja</subject><title>Metabolic syndrome - treatment</title><title>Metabolični sindrom - zdravljenje</title></Record>